Policy options for addressing the high cost of specialty pharmaceuticals
The cost to U.S. consumers of specialty drugs is too high, and cost-sharing obligations are reducing patient access to affordable and life-changing medications. While accounting only for approximately 2% of prescriptions filled, specialty drugs accounted for nearly 45% of the U.S. drug spend in 2018...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2019-12-01
|
| Series: | Global Health Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2414644719302738 |